RGT 0.00% 31.0¢ argent biopharma limited

Ann: $15M FINANCE FACILITY TO FUND REVENUE GROWTH FOR KEY MARKETS, page-95

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 381 Posts.
    lightbulb Created with Sketch. 62
    Jazzyboy, MXC is past the point of future forecasts and what could potentially happen where investors get in early and put faith in management to excel the business in a positive manner for a return to the shareholders, the share price tells you this.

    MXC has been around for 5-6 years has had 50-60 million invested over those years as well. For a return to the shareholder of 2.5c.

    MXC is now all about the figures, deal after deal after deal has not materialised and what deal does, investors are watching the financial reports not paying attention to the fluff announcements.

    Look at the last financial report gross profit was approx. 120k. That’s profit Jazzyboy not revenue, big difference. Then look at all their operational costs, it’s not hard to see this company is in serious trouble.

    The margin on their products that they sell is minimal.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.000(0.00%)
Mkt cap ! $16.82M
Open High Low Value Volume
31.0¢ 31.0¢ 31.0¢ $604 1.948K

Buyers (Bids)

No. Vol. Price($)
1 3921 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 3218 2
View Market Depth
Last trade - 12.55pm 01/11/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.